The Relationship Between Attention Deficit-Hyperactivity Disorder and Kidney Disease in Children and Adolescents: An Emerging Area of Research

authors:

avatar Abolfazl Gilani ORCID 1 , avatar Dhruti Amin 2 , avatar Parsa Yousefichaijan ORCID 3 , avatar Roham Sarmadian 4 , *

Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran
GMERS Medical College and Hospital, Gotri, Vadodara, India
Department of Pediatrics, Arak University of Medical Sciences, Arak, Iran
Infectious Diseases Research Center, Arak University of Medical Sciences, Arak, Iran

how to cite: Gilani A, Amin D, Yousefichaijan P, Sarmadian R. The Relationship Between Attention Deficit-Hyperactivity Disorder and Kidney Disease in Children and Adolescents: An Emerging Area of Research. Iran J Pediatr. 2024;34(1):e137300. https://doi.org/10.5812/ijp-137300.

References

  • 1.

    Yousefichaijan P, Sharafkhah M, Salehi B, Rafiei M. Attention deficit hyperactivity disorder in children with early stages of chronic kidney disease. Med J Islam Repub Iran. 2015;29:181. [PubMed ID: 26034734]. [PubMed Central ID: PMC4431432].

  • 2.

    Yousefichaijan P, Salehi B, Rafiei M, Dahmardnezhad M, Naziri M. The correlation between attention deficit hyperactivity disorder and steroid-dependent nephrotic syndrome. Saudi J Kidney Dis Transpl. 2015;26(6):1205-9. [PubMed ID: 26586060]. https://doi.org/10.4103/1319-2442.168624.

  • 3.

    Yousefichaijan P, Sharafkhah M, Vazirian S, Seyedzadeh A, Rafeie M, Salehi B, et al. Attention-deficit/hyperactivity disorder in children undergoing peritoneal dialysis. Nephro-Urology Monthly. 2015;7(2). https://doi.org/10.5812/numonthly.24427.

  • 4.

    Miranda AS, Cordeiro TM, Dos Santos Lacerda Soares TM, Ferreira RN, Simoes EA. Kidney-brain axis inflammatory cross-talk: from bench to bedside. Clin Sci (Lond). 2017;131(11):1093-105. [PubMed ID: 28515344]. https://doi.org/10.1042/CS20160927.

  • 5.

    Clavenna A, Bonati M. Pediatric pharmacoepidemiology - safety and effectiveness of medicines for ADHD. Expert Opin Drug Saf. 2017;16(12):1335-45. [PubMed ID: 28984477]. https://doi.org/10.1080/14740338.2017.1389894.

  • 6.

    Mokhtari T, Sheikhazadi A, Hassanzadeh G, Safari M, Sheikhbahaei F, Faghir-Ghanesefat H, et al. Potential adverse effects of amphetamines on kidney; a narrative review on current knowledge. J Ren Inj Prev. 2018;7(4):218-23. https://doi.org/10.15171/jrip.2018.51.

  • 7.

    Sullivan MA, Rudnik-Levin F. Attention deficit/hyperactivity disorder and substance abuse. Diagnostic and therapeutic considerations. Ann N Y Acad Sci. 2001;931:251-70. [PubMed ID: 11462745]. https://doi.org/10.1111/j.1749-6632.2001.tb05783.x.